Shah S, Osuala K, Brock E, Ji K, Sloane B, Mattingly R
Cells. 2025; 14(3).
PMID: 39937011
PMC: 11817749.
DOI: 10.3390/cells14030220.
Roozitalab M, Prekete N, Allen M, Grose R, Jones J
Adv Exp Med Biol. 2025; 1464():211-235.
PMID: 39821028
DOI: 10.1007/978-3-031-70875-6_12.
Wang G, Wen P, Xue T, Huang Y, Shao Q, Zhang N
Cell Commun Signal. 2024; 22(1):611.
PMID: 39702199
PMC: 11660853.
DOI: 10.1186/s12964-024-02000-2.
Kobia F, Castro E Almeida L, Paganoni A, Carminati F, Andronache A, Lavezzari F
Life Sci Alliance. 2024; 8(3).
PMID: 39663000
PMC: 11633778.
DOI: 10.26508/lsa.202403122.
Osuala K, Heyza J, Zhao Z, Xu Y, Moin K, Ji K
Cancers (Basel). 2024; 16(22).
PMID: 39594795
PMC: 11593312.
DOI: 10.3390/cancers16223840.
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma.
Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman J, Lopez-Plana A, Bergholtz H
Breast Cancer Res. 2024; 26(1):122.
PMID: 39138514
PMC: 11320849.
DOI: 10.1186/s13058-024-01871-0.
Compressed intracellular motility via non-uniform temporal sampling in dynamic optical coherence tomography.
Oldenburg A, Ji P, Yu X, Yang L
J Biomed Opt. 2024; 29(7):076002.
PMID: 38966847
PMC: 11223688.
DOI: 10.1117/1.JBO.29.7.076002.
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.
Treekitkarnmongkol W, Shah V, Kai K, Katayama H, Wong J, Ladha F
Br J Cancer. 2024; 131(1):171-183.
PMID: 38760444
PMC: 11231151.
DOI: 10.1038/s41416-024-02697-5.
Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers.
Lashen A, Alqahtani S, Shoqafi A, Algethami M, Jeyapalan J, Mongan N
Int J Mol Sci. 2024; 25(9).
PMID: 38732271
PMC: 11084890.
DOI: 10.3390/ijms25095053.
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.
Wang J, Li B, Luo M, Huang J, Zhang K, Zheng S
Signal Transduct Target Ther. 2024; 9(1):83.
PMID: 38570490
PMC: 10991592.
DOI: 10.1038/s41392-024-01779-3.
Spatial Engineering of Mammary Epithelial Cell Cultures with 3D Bioprinting Reveals Growth Control by Branch Point Proximity.
Koskinen L, Nieminen L, Arjonen A, Guzman C, Peurla M, Peuhu E
J Mammary Gland Biol Neoplasia. 2024; 29(1):5.
PMID: 38416267
PMC: 10902034.
DOI: 10.1007/s10911-024-09557-1.
Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research.
Daneshdoust D, Luo M, Li Z, Mo X, Alothman S, Kallakury B
Cells. 2023; 12(19).
PMID: 37830602
PMC: 10572051.
DOI: 10.3390/cells12192388.
Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.
Mezawa Y, Wang T, Daigo Y, Takano A, Miyagi Y, Yokose T
Cancer Sci. 2023; 114(11):4376-4387.
PMID: 37706357
PMC: 10637058.
DOI: 10.1111/cas.15955.
MIND the translational gap: Preclinical models of ductal carcinoma in situ.
Hutten S, Jonkers J
Clin Transl Med. 2023; 13(8):e1376.
PMID: 37620984
PMC: 10449811.
DOI: 10.1002/ctm2.1376.
Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer.
Yuan M, Barefoot M, Peterson K, Campbell M, Blancato J, Chen M
Int J Mol Sci. 2023; 24(14).
PMID: 37511268
PMC: 10380654.
DOI: 10.3390/ijms241411505.
IGFBP2 secretion by mammary adipocytes limits breast cancer invasion.
Conway J, Dinc D, Follain G, Paavolainen O, Kaivola J, Bostrom P
Sci Adv. 2023; 9(28):eadg1840.
PMID: 37436978
PMC: 10337915.
DOI: 10.1126/sciadv.adg1840.
Mechanisms of action of NME metastasis suppressors - a family affair.
Prunier C, Chavrier P, Boissan M
Cancer Metastasis Rev. 2023; 42(4):1155-1167.
PMID: 37353690
PMC: 10713741.
DOI: 10.1007/s10555-023-10118-x.
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.
Hutten S, de Bruijn R, Lutz C, Badoux M, Eijkman T, Chao X
Cancer Cell. 2023; 41(5):986-1002.e9.
PMID: 37116492
PMC: 10171335.
DOI: 10.1016/j.ccell.2023.04.002.
Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer.
Fang W, Medrano M, Cote P, Portsche M, Rao V, Hong Y
Front Oncol. 2023; 13:1130911.
PMID: 37091166
PMC: 10118028.
DOI: 10.3389/fonc.2023.1130911.
The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription Factor FOXQ1 to Promote Breast Cancer Cell Growth.
Lin Y, Lin F, Zhang Z, Peng L, Yang W, Yang M
Int J Biol Sci. 2023; 19(3):744-759.
PMID: 36778115
PMC: 9909991.
DOI: 10.7150/ijbs.74574.
